Scientists at Lawson Research Institute (Lawson) of St. Joseph’s Health Care London and London Health Sciences Centre Research Institute (LHSCRI) are the first in the world to study fecal transplants using capsules containing microbes from the gut of healthy volunteers to improve the response of patients with advanced pancreatic cancer to chemotherapy. 

Coronary artery disease (CAD), or the narrowing of the coronary arteries, is the leading cause of morbidity and mortality throughout the world. Atherosclerosis, or the buildup of plaque in the arteries, develops when low-density lipoprotein cholesterol (LDL-C) enters the blood vessel walls through dysfunctional endothelial cells (EC), leading to the formation of plaques. Researchers from Mass General Brigham developed a polygenic risk score that examines genes associated with EC function to identify individuals with higher CAD risk. Their results are published in Nature Medicine.

26.02.2025/Kiel. The south-western Baltic Sea has about 3,000 kilograms of dissolved toxic chemicals released from unexploded ordnance, according to a new study by the GEOMAR Helmholtz Centre for Ocean Research Kiel. The substances were detected in almost all water samples taken in 2017 and 2018, with particularly high concentrations in the Bights of Kiel and Lübeck. The levels are still below thresholds for health risk, but highlight the urgent need for munitions clearance to minimise long-term risks. The study has now been published in the journal Chemosphere.

A recent study led by the Hospital del Mar Research Institute and published by Frontiers in Psychiatry demonstrates the link between antidepressants and weight gain.Using follow-up data from participants in the REGICOR study (Registre Gironí del Cor), researchers quantified an average 2% increase in body weight among individuals undergoing this type of treatment.

Drawing inspiration from the tardigrade, researchers developed a new strategy that may protect cancer patients from the side effects of radiation therapy.

 

Frontiers is pleased to announce the continuation of its partnership with the German National Library of Medicine (ZB MED) into a second year. Building on the successful collaboration established in 2024, this agreement reinforces our shared commitment to advancing open science by providing researchers across Germany with seamless, cost-effective access to gold open access publishing.